These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

999 related items for PubMed ID: 31602161

  • 1. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT, Guo CQ, Cui GH, Zhao S.
    World J Gastroenterol; 2019 Oct 07; 25(37):5604-5618. PubMed ID: 31602161
    [Abstract] [Full Text] [Related]

  • 2. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y.
    Tumour Biol; 2016 Apr 07; 37(4):4383-91. PubMed ID: 26499784
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
    Gong L, Mao W, Chen Q, Jiang Y, Fan Y.
    Cancer Chemother Pharmacol; 2019 Apr 07; 83(4):639-647. PubMed ID: 30643929
    [Abstract] [Full Text] [Related]

  • 9. Plasma-derived Exosomal miR-25-3p and miR-23b-3p as Predictors of Response to Chemoradiotherapy in Esophageal Squamous Cell Carcinoma.
    Jing Z, Guo Z, Zhang C.
    Technol Cancer Res Treat; 2024 Apr 07; 23():15330338241289520. PubMed ID: 39380461
    [Abstract] [Full Text] [Related]

  • 10. Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma.
    Li SP, Su HX, Zhao D, Guan QL.
    Med Sci Monit; 2016 Jun 27; 22():2195-201. PubMed ID: 27345473
    [Abstract] [Full Text] [Related]

  • 11. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y, Lyu J, Jia H, Liang L, Xiao L, Liu Y, Liu X, Li K, Chen T, Zhang R, Zhang H, Tang C, Li T.
    Future Oncol; 2021 Jul 27; 17(20):2647-2657. PubMed ID: 34008415
    [Abstract] [Full Text] [Related]

  • 12. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
    Zhao Z, Zhang Y, Wang X, Geng X, Zhu L, Li M.
    Cancer Med; 2020 Aug 27; 9(16):5881-5888. PubMed ID: 32627960
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J, Chen M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct 28; 43(10):1048-1053. PubMed ID: 30523223
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy.
    Niwa Y, Yamada S, Sonohara F, Kurimoto K, Hayashi M, Tashiro M, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Kodera Y.
    J Transl Med; 2019 Jan 03; 17(1):1. PubMed ID: 30602370
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J, Song K, Feng X, Gao S.
    Biochem Biophys Res Commun; 2016 Apr 29; 473(2):363-9. PubMed ID: 26777997
    [Abstract] [Full Text] [Related]

  • 17. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
    Sun N, Ye L, Chang T, Li X, Li X.
    Int J Clin Exp Pathol; 2014 Apr 29; 7(10):6871-9. PubMed ID: 25400770
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.
    PLoS One; 2014 Apr 29; 9(3):e92292. PubMed ID: 24651474
    [Abstract] [Full Text] [Related]

  • 19. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.
    Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P.
    Oncotarget; 2017 May 23; 8(21):34468-34480. PubMed ID: 28380431
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.